Learn how to ensure data completeness, consistency and accuracy in the modern trial era in this playbook.
New trends and technologies are evolving rapidly, including advancements in EHR interoperability, artificial intelligence, and the growing use of patient-sourced data from devices like wearables. Research has also shown increased complexity, depth, and reach in decentralized and adaptive study designs, and diversity and inclusion initiatives. These complexities affect the usage of real-world data along a product’s journey to market, influencing what data is collected, when and how it is used, and for what purposes.
Along with digging into how the 21st Century Cures Act of 2016 established policy impetus for RWE, the playbook offers insights from subject-matter experts from Cardinal Health. Read now to access guidance for:
- Boosting data completeness, consistency and accuracy
- Approaching your RWE plan from the inside out
- Investing in RWE for the long term
Offered Free by: BioPharma Dive’s studioID and Cardinal Health
See All Resources from: BioPharma Dive’s studioID and Cardinal Health
